Cyclopharm Ltd has released a press release.
CYC 1H2025 Results Summary
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cyclopharm
- Half Yearly Report and Accounts
- Cyclopharm Secures Maximum US Patent Extension for Technegas
- Technegas US Momentum Accelerates with $US1m Sales Milestone
- Company Update
- CYC signs 5-year Agreement with USA Veterans Administration
Later from Cyclopharm
- S&P DJI Announces September 2025 Quarterly Rebalance
- Legal Proceedings
- Cyclopharm Bell Potter Healthcare Conference Presentation
- Colombia Approval Marks 67th Country for Technegas
- Stanford Children's Health to Implement Technegas
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm